Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

10 results
Display

Influence of Insurance Benefit Criteria on the Administration Rate of Osteoporosis Drugs in Postmenopausal Females

Lee JH, Lee YH, Moon SH, Lee YS, The Prevalence of Osteoporotic Vertebral Compression Fractures in Korean Post Menopausal Women Study Group

BACKGROUND: Preventive measures need to be implemented to lower the incidence of osteoporotic fractures. Osteoporotic fractures increase morbidity and mortality as well as impose a socioeconomic burden; however, current research...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto

PURPOSE: The comparative effects of alendronate and alfacalcidol on bone mineral density (BMD) and bone turnover have already been established in postmenopausal women with osteoporosis. An open-labeled prospective study was...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Osteoporotic Hip Fracture in the Elderly Patients: Physicians' Views

Lee YK, Koo KH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Effects of Alendronate and Raloxifene on Lumbar Bone Mineral Density, Bone Turnover, and Lipid Metabolism in Elderly Women with Osteoporosis

Iwamoto J, Sato Y, Uzawa M, Takeda T, Matsumoto

  • KMID: 2396095
  • Yonsei Med J.
  • 2008 Feb;49(1):119-128.
PURPOSE: To compare the effects of alendronate and raloxifene on lumbar bone mineral density (BMD), bone turnover, and lipid metabolism in elderly women with osteoporosis. Subjects and Methods: One hundred...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter to the Editor: Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis

Marcuzzi A, Zanin V, Vuch J, Pontillo A, Crovella S

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Spontaneous Non-Traumatic Stress Fractures in Bilateral Femoral Shafts in a Patient Treated with Bisphosphonates

Shin DY, Ku CR, Kim KM, Choi HS, Rhee Y, Lee EJ, Lim SK

Bisphosphonates are potent inhibitors of bone resorption and widely used to treat osteoporosis. Extensive studies have shown that therapy with bisphosphonates improves bone density and decreases fracture risk. However, concerns...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Vitamin K2 on the Development of Osteopenia in Rats as the Models of Osteoporosis

Iwamoto J, Takeda T, Sato Y

Vitamin K2 is widely used for the treatment of osteoporosis in Japan. To understand the effects of vitamin K2 on bone mass and bone metabolism, we reviewed its effects on...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute Effects of Intravenous Administration of Pamidronate in Patients with Osteoporosis

Lim MJ, Kwon SR, Park SG, Park W

We investigated acute effects of intermittent large dose bisphophonate therapy in osteoporotic patients. Peripheral blood mononuclear cells were incubated with alendronate (100 micrometer) for 18 hr, in vitro and cytokine...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gastrointestinal Side Effect Profile Due to the Use of Alendronate in the Treatment of Osteoporosis

Aki S, Eskiyurt N, Akarirmak , Tuzun F, Eryavuz M, Alper S, Arpacioglu O, Atalay F, Kavuncu V, Kokino S, Kuru O, Nas K, Ozerbil O, Savas G, Sendur OF, Soy D, Akyuz G

The aim of our study was to evaluate the upper gastrointestinal (GI) tract side effect profile in 759 female patients that had taken alendronate (10 mg/day), for at least 6...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Comparison of Estrogen and Two Different Doses of Calcitonin in Ovariectomized Rats

Kavuncu V, Sahin S, Baydas G, Ilhan N, Ozercan I, Yasar A, Pekkutucu , Ilhan N, Ozercan R

The purpose of this study was to investigate the treatment efficacies of salmon calcitonin (SC) and estrogen in a type-I osteoporotic rat model. Sixty, 3-month-old, female Wistar rats were divided...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr